Interleukin-11 Signals through the Formation of a Hexameric Receptor Complex*

Interleukin-11 (IL-11) is a member of the gp130 family of cytokines. These cytokines drive the assembly of multisubunit receptor complexes, all of which contain at least one molecule of the transmembrane signaling receptor gp130. IL-11 has been shown to induce gp130-dependent signaling through the formation of a high affinity complex with the IL-11 receptor (IL-11R) and gp130. Site-directed mutagenesis studies have identified three distinct receptor binding sites of IL-11, which enable it to form this high affinity receptor complex. Here we present data from immunoprecipitation experiments, using differentially tagged forms of ligand and soluble receptor components, which show that multiple copies of IL-11, IL-11R, and gp130 are present in the receptor complex. Furthermore, it is demonstrated that sites II and III of IL-11 are independent gp130 binding epitopes and that both are essential for gp130 dimerization. We also show that a stable high affinity complex of IL-11, IL-11R, and gp130 can be resolved by nondenaturing polyacrylamide gel electrophoresis, and its composition verified by second dimension denaturing polyacrylamide gel electrophoresis. Results indicate that the three receptor binding sites of IL-11 and the Ig-like domain of gp130 are all essential for this stable receptor complex to be formed. We therefore propose that IL-11 forms a hexameric receptor complex composed of two molecules each of IL-11, IL-11R, and gp130.

[1]  P. Heinrich,et al.  Different epitopes are required for gp130 activation by interleukin‐6, oncostatin M and leukemia inhibitory factor , 2000, FEBS letters.

[2]  S. Chevalier,et al.  Identification of a gp130 Cytokine Receptor Critical Site Involved in Oncostatin M Response* , 2000, The Journal of Biological Chemistry.

[3]  R. Schroeder,et al.  Modulation of RNA function by aminoglycoside antibiotics , 2000, The EMBO journal.

[4]  W. Trepicchio,et al.  Hematopoietic, immunomodulatory and epithelial effects of interleukin-11 , 1999, Leukemia.

[5]  S. Rose-John,et al.  IL-6 Type Cytokine Receptor Complexes: Hexamer, Tetramer or Both? , 1999, Biological chemistry.

[6]  J. Heath,et al.  Identification of Three Distinct Receptor Binding Sites of Murine Interleukin-11* , 1999, The Journal of Biological Chemistry.

[7]  P. Heinrich,et al.  Activation of the signal transducer glycoprotein 130 by both IL-6 and IL-11 requires two distinct binding epitopes. , 1999, Journal of immunology.

[8]  J. Heath,et al.  The interactions of the cytokine-binding homology region and immunoglobulin-like domains of gp130 with oncostatin M: implications for receptor complex formation. , 1998, Protein engineering.

[9]  P. Heinrich,et al.  Interleukin-6-type cytokine signalling through the gp130/Jak/STAT pathway. , 1998, The Biochemical journal.

[10]  D. Hilton,et al.  The Immunoglobulin-like Module of gp130 Is Required for Signaling by Interleukin-6, but Not by Leukemia Inhibitory Factor* , 1998, The Journal of Biological Chemistry.

[11]  M. Feldmann,et al.  Important immunoregulatory role of interleukin-11 in the inflammatory process in rheumatoid arthritis. , 1998, Arthritis and rheumatism.

[12]  D. Roopenian,et al.  Maternal IL-11Ralpha function is required for normal decidua and fetoplacental development in mice. , 1998, Genes & development.

[13]  G. Ciliberto,et al.  Activation of the signal transducer gp130 by interleukin-11 and interleukin-6 is mediated by similar molecular interactions. , 1998, The Biochemical journal.

[14]  J. Heath,et al.  Crystal structure of a cytokine‐binding region of gp130 , 1998, The EMBO journal.

[15]  C. Begley,et al.  Infertility in female mice lacking the receptor for interleukin 11 is due to a defective uterine response to implantation , 1998, Nature Medicine.

[16]  M. Layton,et al.  The Unusual Species Cross-reactivity of the Leukemia Inhibitory Factor Receptor α-Chain Is Determined Primarily by the Immunoglobulin-like Domain* , 1997, The Journal of Biological Chemistry.

[17]  P. Heinrich,et al.  Molecular Modeling-guided Mutagenesis of the Extracellular Part of gp130 Leads to the Identification of Contact Sites in the Interleukin-6 (IL-6)·IL-6 receptor·gp130 Complex* , 1997, The Journal of Biological Chemistry.

[18]  D. Williams,et al.  Interleukin-11: review of molecular, cell biology, and clinical use. , 1997, Blood.

[19]  L. D. Ward,et al.  Interleukin‐6: Structure‐function relationships , 1997, Protein science : a publication of the Protein Society.

[20]  W. Somers,et al.  1.9 Å crystal structure of interleukin 6: implications for a novel mode of receptor dimerization and signaling , 1997, The EMBO journal.

[21]  G. Ciliberto,et al.  Functional Expression of Soluble Human Interleukin-11 (IL-11) Receptor α and Stoichiometry of in Vitro IL-11 Receptor Complexes with gp130* , 1996, The Journal of Biological Chemistry.

[22]  J. Heath,et al.  Mediation of interleukin-11-dependent biological responses by a soluble form of the interleukin-11 receptor. , 1996, The Biochemical journal.

[23]  R. Laufer,et al.  Identification of ciliary neurotrophic factor (CNTF) residues essential for leukemia inhibitory factor receptor binding and generation of CNTF receptor antagonists. , 1996, Proceedings of the National Academy of Sciences of the United States of America.

[24]  J. Heath,et al.  Characterization of the Receptor Binding Sites of Human Leukemia Inhibitory Factor and Creation of Antagonists (*) , 1996, The Journal of Biological Chemistry.

[25]  W. McCaskill-Stevens,et al.  A phase I trial of recombinant human interleukin-11 (neumega rhIL-11 growth factor) in women with breast cancer receiving chemotherapy. , 1996, Blood.

[26]  C. Begley,et al.  The human IL-11 receptor requires gp130 for signalling: demonstration by molecular cloning of the receptor. , 1996, Oncogene.

[27]  Yang Yc,et al.  Activation of Src-family protein tyrosine kinases and phosphatidylinositol 3-kinase in 3T3-L1 mouse preadipocytes by interleukin-11. , 1996 .

[28]  G. Ciliberto,et al.  Definition of a Composite Binding Site for gp130 in Human Interleukin-6 (*) , 1995, The Journal of Biological Chemistry.

[29]  M. Marshall,et al.  Interleukin-11 Induces Complex Formation of Grb2, Fyn, and JAK2 in 3T3L1 Cells (*) , 1995, The Journal of Biological Chemistry.

[30]  S. Sonis,et al.  Alteration in the frequency, severity and duration of chemotherapy-induced mucositis in hamsters by interleukin-11. , 1995, European journal of cancer. Part B, Oral oncology.

[31]  W. Hendrickson,et al.  Localization of Functional Receptor Epitopes on the Structure of Ciliary Neurotrophic Factor Indicates a Conserved, Function-related Epitope Topography among Helical Cytokines (*) , 1995, The Journal of Biological Chemistry.

[32]  W. Hendrickson,et al.  Crystal structure of dimeric human ciliary neurotrophic factor determined by MAD phasing. , 1995, The EMBO journal.

[33]  G. Ciliberto,et al.  Two distinct and independent sites on IL‐6 trigger gp 130 dimer formation and signalling. , 1995, The EMBO journal.

[34]  C. Begley,et al.  Cloning of a murine IL‐11 receptor alpha‐chain; requirement for gp130 for high affinity binding and signal transduction. , 1994, The EMBO journal.

[35]  L. D. Ward,et al.  High affinity interleukin-6 receptor is a hexameric complex consisting of two molecules each of interleukin-6, interleukin-6 receptor, and gp-130. , 1994, The Journal of biological chemistry.

[36]  D. Stuart,et al.  The crystal structure and biological function of leukemia inhibitory factor: Implications for receptor binding , 1994, Cell.

[37]  A. Porter,et al.  Efficient and Rapid Affinity Purification of Proteins Using Recombinant Fusion Proteases , 1994, Bio/Technology.

[38]  Y. Yang,et al.  Mitogen-activated protein kinases and ribosomal S6 protein kinases are involved in signaling pathways shared by interleukin-11, interleukin-6, leukemia inhibitory factor, and oncostatin M in mouse 3T3-L1 cells. , 1994, The Journal of biological chemistry.

[39]  D. Cosman.  The hematopoietin receptor superfamily. , 1993, Cytokine.

[40]  M. Ultsch,et al.  Human growth hormone and extracellular domain of its receptor: crystal structure of the complex. , 1992, Science.

[41]  G. Yancopoulos,et al.  The receptor for ciliary neurotrophic factor. , 1991, Science.

[42]  T. Hirano,et al.  Molecular cloning and expression of an IL-6 signal transducer, gp130 , 1990, Cell.

[43]  J. Bazan,et al.  Structural design and molecular evolution of a cytokine receptor superfamily. , 1990, Proceedings of the National Academy of Sciences of the United States of America.

[44]  F. D. Di Padova,et al.  Structure-function analysis of human IL-6. Epitope mapping of neutralizing monoclonal antibodies with amino- and carboxyl-terminal deletion mutants. , 1990, Journal of immunology.

[45]  T. Taniguchi,et al.  Cloning and expression of the human interleukin-6 (BSF-2/IFN beta 2) receptor. , 1988, Science.

[46]  J. Miller,et al.  Analysis of mutation in human cells by using an Epstein-Barr virus shuttle system , 1987, Molecular and cellular biology.

[47]  W. Ansorge.  Fast and sensitive detection of protein and DNA bands by treatment with potassium permanganate. , 1985, Journal of biochemical and biophysical methods.

[48]  T. Kishimoto,et al.  Gp130 and the interleukin-6 family of cytokines. , 1997, Annual review of immunology.